Crossref journal-article
Elsevier BV
Toxicology and Applied Pharmacology (78)
Bibliography

Tseng, C.-H. (2004). The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicology and Applied Pharmacology, 197(2), 67–83.

Authors 1
  1. Chin-Hsiao Tseng (first)
References 158 Referenced 252
  1. 10.1159/000177995 / Ann. Nutr. Metab. / Effects of arsenic (V)–chromium (III) interaction on plasma glucose and cholesterol levels in growing rats by Aguilar (1997)
  2. 10.2337/diacare.27.2007.S5 / Diabetes Care / Diagnosis and classification of diabetes mellitus by American Diabetes Association (2004)
  3. 10.1177/026010600201600403 / Nutr. Health / Decreased serum magnesium and zinc levels: atherogenic implications in type-2 diabetes mellitus in Nigerians by Anetor (2002)
  4. 10.1021/tx000114o / Chem. Res. Toxicol. / Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic by Aposhian (2000)
  5. 10.1053/jfms.2001.0157 / J. Feline Med. Surg. / Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats by Appleton (2002)
  6. 10.1074/jbc.M301174200 / J. Biol. Chem. / Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells by Arnette (2003)
  7. 10.1093/carcin/21.11.2097 / Carcinogenesis / Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair by Asmuss (2000)
  8. 10.1385/BTER:85:2:097 / Biol. Trace Elem. Res. / Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status by Bahijri (2002)
  9. 10.1074/jbc.272.4.2551 / J. Biol. Chem. / Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport by Bandyopadhyay (1997)
  10. 10.1074/jbc.M007920200 / J. Biol. Chem. / Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter by Bandyopadhyay (2001)
  11. 10.1074/jbc.M106042200 / J. Biol. Chem. / Glucose activates protein kinase C-zeta/lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D: a novel mechanism for activating glucose transporter translocation by Bandyopadhyay (2001)
  12. 10.1016/0891-5849(96)00174-8 / Free Radical Biol. Med. / Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells by Barchowsky (1996)
  13. 10.1006/taap.1999.8723 / Toxicol. Appl. Pharmacol. / Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways by Barchowsky (1999)
  14. 10.1023/A:1006819227506 / Mol. Cell. Biochem. / Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats by Battell (1998)
  15. 10.1046/j.1432-1033.2003.03771.x / Eur. J. Biochem. / Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity by Bazuine (2003)
  16. {'key': '10.1016/j.taap.2004.02.009_BIB16', 'first-page': 'E14', 'article-title': 'Phenylarsine oxide inhibits insulin-stimulated protein phosphatase 1 activity and GLUT-4 translocation', 'volume': '267', 'author': 'Begum', 'year': '1994', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Phenylarsine oxide inhibits insulin-stimulated protein phosphatase 1 activity and GLUT-4 translocation by Begum (1994)
  17. 10.1172/JCI109972 / J. Clin. Invest. / Inhibition of renal metabolism. Relative effects of arsenate on sodium, phosphate, and glucose transport by the rabbit proximal tubule by Brazy (1980)
  18. 10.2337/diabetes.52.9.2338 / Diabetes / Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism by Bruce (2003)
  19. 10.1007/BF02784618 / Biol. Trace Elem. Res. / Zinc and copper in the serum of diabetic patients by Car (1992)
  20. 10.1016/0047-6374(89)90002-X / Mech. Ageing Dev. / Differences in the influence of diet on hepatic glutathione S-transferase activity and glutathione content between young and old C57 black female mice by Carrillo (1989)
  21. 10.1093/jn/132.6.1107 / J. Nutr. / Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats by Cefalu (2002)
  22. 10.1161/01.ATV.8.5.452 / Arteriosclerosis / Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease by Chen (1988)
  23. 10.1161/01.HYP.25.1.53 / Hypertension / Increased prevalence of hypertension and long-term arsenic exposure by Chen (1995)
  24. 10.1007/BF02789414 / Biol. Trace Elem. Res. / Selected metals status in patients with noninsulin-dependent diabetes mellitus by Chen (1995)
  25. 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9 / J. Cell. Physiol. / Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis by Chen (1998)
  26. 10.1093/clinchem/45.1.7 / Clin. Chem. / New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases by Chen (1999)
  27. 10.1161/01.STR.28.9.1717 / Stroke / Dose–response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic by Chiou (1997)
  28. 10.1007/s00125-003-1304-4 / Diabetologia / Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes? by Clark (2004)
  29. 10.1172/JCI114940 / J. Clin. Invest. / Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism by Consoli (1990)
  30. 10.1159/000177521 / Ann. Nutr. Metab. / Experimental selenium toxicity in guinea pigs: biochemical studies by Das (1989)
  31. 10.1021/tx00041a006 / Chem. Res. Toxicol. / Complexation of arsenic species in rabbit erythrocytes by Delnomdedieu (1994)
  32. 10.1016/0009-2797(95)03636-Z / Chem. Biol. Interact. / Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytes by Delnomdedieu (1995)
  33. 10.1016/S0026-0495(98)90357-2 / Metabolism / Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus by De Mattia (1998)
  34. 10.1016/S0027-5107(02)00143-4 / Mutat. Res. / Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes by Dincer (2002)
  35. 10.1016/0167-4889(88)90050-X / Biochim. Biophys. Acta / The action of phenylarsine oxide on the stereospecific uptake of d-glucose in basal and insulin-stimulated rat adipocytes by Douen (1988)
  36. 10.1007/s11745-998-0220-z / Lipids / Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes by Douillet (1998)
  37. 10.1096/fj.02-0287fje / FASEB J. / Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals by Drobna (2003)
  38. 10.1385/BTER:94:3:193 / Biol. Trace Elem. Res. / Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus by Ekin (2003)
  39. 10.1385/BTER:79:3:205 / Biol. Trace Elem. Res. / Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls by Ekmekcioglu (2001)
  40. 10.1056/NEJMra002168 / N. Engl. J. Med. / Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young by Fajans (2001)
  41. 10.1016/0043-1354(72)90052-8 / Water Res. / A review of the arsenic cycle in natural waters by Ferguson (1972)
  42. 10.2337/diabetes.52.9.2346 / Diabetes / The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey by Ford (2003)
  43. 10.1016/S0021-9258(18)89409-1 / J. Biol. Chem. / Evidence for the involvement of vicinal sulfhydryl groups in insulin-inactivated hexose transport by 3T3-L1 adipocytes by Frost (1985)
  44. 10.1016/S0021-9258(18)48014-3 / J. Biol. Chem. / Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes by Frost (1987)
  45. 10.1042/bj2350001 / Biochem. J. / Protein kinase activity of the insulin receptor by Gammeltoft (1986)
  46. 10.1016/S0300-483X(99)00202-4 / Toxicology / Confounding variables in the environmental toxicology of arsenic by Gebel (2000)
  47. 10.1016/S0955-2863(02)00220-6 / J. Nutr. Biochem. / Role of chromium supplementation in Indians with type 2 diabetes mellitus by Ghosh (2002)
  48. 10.1242/jcs.112.24.4793 / J. Cell Sci. / Association of AP1 adaptor complexes with GLUT4 vesicles by Gillingham (1999)
  49. 10.1093/toxsci/56.1.18 / Toxicol. Sci. / Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats by Gregus (2000)
  50. 10.1016/S0021-9258(19)69115-5 / J. Biol. Chem. / ADP-arsenate. Formation by submitochondrial particles under phosphorylating conditions by Gresser (1981)
  51. 10.1152/ajpgi.00423.2002 / Am. J. Physiol.: Gastrointest. Liver Physiol. / Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action by Guarino (2003)
  52. 10.1016/S1383-5718(98)00076-X / Mutat. Res. / Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei by Gurr (1998)
  53. 10.1152/ajpendo.00355.2002 / Am. J. Physiol.: Endocrinol. Metab. / N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress by Haber (2003)
  54. 10.1016/j.mrfmmm.2003.08.025 / Mutat. Res. / Signaling by carcinogenic metals and metal-induced reactive oxygen species by Harris (2003)
  55. 10.2337/diabetes.49.4.527 / Diabetes / Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism by Hayashi (2000)
  56. {'key': '10.1016/j.taap.2004.02.009_BIB56', 'first-page': '126', 'article-title': 'Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus', 'volume': '3', 'author': 'Hayden', 'year': '2002', 'journal-title': 'J. Orthod. Pract.'} / J. Orthod. Pract. / Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus by Hayden (2002)
  57. {'key': '10.1016/j.taap.2004.02.009_BIB57', 'first-page': '86', 'article-title': 'Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus', 'volume': '3', 'author': 'Hayden', 'year': '2002', 'journal-title': 'J. Orthod. Pract.'} / J. Orthod. Pract. / Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus by Hayden (2002)
  58. 10.1002/jcb.10395 / J. Cell. Biochem. / Insulin-like and non-insulin-like selenium actions in 3T3-L1 adipocytes by Heart (2003)
  59. 10.1152/ajpcell.1990.258.4.C648 / Am. J. Physiol. / Effects of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle by Henriksen (1990)
  60. {'key': '10.1016/j.taap.2004.02.009_BIB60', 'first-page': '119', 'article-title': 'Relationship between insulin resistance and oxidative stress in vivo', 'volume': '42', 'author': 'Hitsumoto', 'year': '2003', 'journal-title': 'J. Cardiol.'} / J. Cardiol. / Relationship between insulin resistance and oxidative stress in vivo by Hitsumoto (2003)
  61. 10.1046/j.1525-1373.1999.d01-137.x / Proc. Soc. Exp. Biol. Med. / Antioxidants, NFkappaB activation, and diabetogenesis by Ho (1999)
  62. 10.1096/fasebj.13.13.1845 / FASEB J. / Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice by Ho (1999)
  63. 10.1016/S0039-9140(97)00111-2 / Talanta / Determination of urinary trace elements (As, Hg, Zn, Pb, Se) in patients with blackfoot disease by Horng (1997)
  64. 10.1038/bjc.1995.22 / Br. J. Cancer / Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status by Hsueh (1995)
  65. 10.1016/S0021-9150(98)00178-6 / Atherosclerosis / Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure by Hsueh (1998)
  66. {'key': '10.1016/j.taap.2004.02.009_BIB66', 'first-page': '83', 'article-title': 'Influence of inorganic and organic arsenicals on intestinal transfer of nutrients', 'volume': '80', 'author': 'Hunder', 'year': '1993', 'journal-title': 'Res. Commun. Chem. Pathol. Pharmacol.'} / Res. Commun. Chem. Pathol. Pharmacol. / Influence of inorganic and organic arsenicals on intestinal transfer of nutrients by Hunder (1993)
  67. 10.1046/j.1463-1326.2002.00195.x / Diabetes Obes. Metab. / Effects of arachidonic acid plus zinc on glucose disposal in genetically diabetic (ob/ob) mice by Hwang (2002)
  68. 10.1074/jbc.274.37.26003 / J. Biol. Chem. / Transport function and regulation of mitochondrial uncoupling proteins 2 and 3 by Jaburek (1999)
  69. 10.1016/S0021-9258(18)54563-4 / J. Biol. Chem. / Phenylarsine oxide causes an insulin-dependent, GLUT4-specific degradation in rat adipocytes by Jhun (1991)
  70. 10.1038/35154 / Nature / PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines by Jiang (1998)
  71. 10.1007/s00125-002-1009-0 / Diabetologia / The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes by Kahn (2003)
  72. 10.1074/jbc.M007030200 / J. Biol. Chem. / The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic by Kala (2000)
  73. 10.1289/ehp.01109245 / Environ. Health Perspect. / Arsenic alters the function of the glucocorticoid receptor as a transcription factor by Kaltreider (2001)
  74. 10.2337/diacare.27.2.631 / Diabetes Care / Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men by Katsuki (2004)
  75. 10.1074/jbc.M301198200 / J. Biol. Chem. / Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells by Khoo (2003)
  76. 10.1006/taap.2001.9157 / Toxicol. Appl. Pharmacol. / Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites by Kitchin (2001)
  77. 10.1002/em.10192 / Environ. Mol. Mutagen. / Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations by Kligerman (2003)
  78. 10.1007/s00125-003-1196-3 / Diabetologia / Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients by Koistinen (2003)
  79. 10.1248/cpb.51.1006 / Chem. Pharm. Bull. (Tokyo) / Insulinomimetic zinc(II) complexes with natural products: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus by Kojima (2003)
  80. 10.1128/MCB.18.12.6971 / Mol. Cell. Biol. / Requirement of atypical protein kinase c-lambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes by Kotani (1998)
  81. 10.1172/JCI200319774 / J. Clin. Invest. / Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction by Krauss (2003)
  82. 10.1006/faat.1994.1075 / Fundam. Appl. Toxicol. / Zinc-induced arsenite tolerance in mice by Kreppel (1994)
  83. 10.1016/j.bbrc.2003.10.013 / Biochem. Biophys. Res. Commun. / Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone by Lagathu (2003)
  84. 10.1093/oxfordjournals.aje.a117031 / Am. J. Epidemiol. / Ingested inorganic arsenic and prevalence of diabetes mellitus by Lai (1994)
  85. 10.1046/j.0022-202X.2003.22109.x / J. Invest. Dermatol. / Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kB and activator protein-1 activity by Laio (2004)
  86. 10.1074/jbc.270.22.12953 / J. Biol. Chem. / An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor gamma (PPAR gamma) by Lehmann (1995)
  87. 10.1007/BF03033191 / Neurotox. Res. / Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy by Lelkes (2001)
  88. 10.2337/diacare.24.3.588 / Diabetes Care / Recent advances in our understanding of insulin action and insulin resistance by Le Roith (2001)
  89. 10.1039/AN9921700681 / Analyst / Influence of organic and inorganic arsenicals on glucose uptake in Madin–Darby canine kidney (MDCK) cells by Liebl (1992)
  90. 10.1007/s002040050194 / Arch. Toxicol. / Influence of glucose on the toxicity of oxophenylarsine in MDCK cells by Liebl (1995)
  91. 10.1007/BF02990138 / Biol. Trace Elem. Res. / Arsenic, selenium, and zinc in patients with Blackfoot disease by Lin (1988)
  92. 10.1073/pnas.031482998 / Proc. Natl. Acad. Sci. U.S.A. / Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity by Liu (2001)
  93. 10.2337/diacare.27.1.134 / Diabetes Care / Magnesium intake and risk of type 2 diabetes in men and women by Lopez-Ridaura (2004)
  94. 10.1016/S0891-5849(97)00279-7 / Free Radical Biol. Med. / Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide by Lynn (1998)
  95. 10.1161/01.RES.86.5.514 / Circ. Res. / NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells by Lynn (2000)
  96. 10.1007/s00125-003-1159-8 / Diabetologia / Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets by MacDonald (2003)
  97. 10.1210/jc.84.4.1165 / J. Clin. Endocrinol. Metab. / Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment by Mahler (1999)
  98. 10.1021/tx000246h / Chem. Res. Toxicol. / Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India by Mandal (2001)
  99. 10.1016/S0531-5565(03)00004-4 / Exp. Gerontol. / Islet amyloid polypeptide and type 2 diabetes by Marzban (2003)
  100. 10.1073/pnas.77.12.7137 / Proc. Natl. Acad. Sci. U.S.A. / Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries by Massague (1980)
  101. 10.1016/S0021-9258(18)89754-X / J. Biol. Chem. / The inhibition of hexose transport by permeant and impermeant sulfhydryl agents in rat adipocytes by May (1985)
  102. {'key': '10.1016/j.taap.2004.02.009_BIB102', 'first-page': '198', 'article-title': 'Arsenic-related health problems among hospital patients in southern Bangladesh', 'volume': '20', 'author': 'Mitra', 'year': '2002', 'journal-title': 'J. Health Popul. Nutr.'} / J. Health Popul. Nutr. / Arsenic-related health problems among hospital patients in southern Bangladesh by Mitra (2002)
  103. 10.1016/S0021-9258(18)32402-5 / J. Biol. Chem. / Synthesis and hydrolysis of ADP-arsenate by beef heart submitochondrial particles by Moore (1983)
  104. 10.1016/S0024-3205(01)01545-4 / Life Sci. / Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines by Nakagawa (2002)
  105. 10.1002/ijc.10471 / Int. J. Cancer / Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism by Nishikawa (2001)
  106. 10.1110/ps.03116403 / Protein Sci. / Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer by Olsen (2003)
  107. 10.1146/annurev.nu.16.070196.001315 / Annu. Rev. Nutr. / Structure, function, and regulation of the mammalian facilitative glucose transporter gene family by Olson (1996)
  108. {'key': '10.1016/j.taap.2004.02.009_BIB108', 'first-page': '1', 'article-title': 'Biochemistry of some toxic agents. I. Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning', 'volume': '97', 'author': 'Peters', 'year': '1955', 'journal-title': 'Bull. Johns Hopkins Hosp.'} / Bull. Johns Hopkins Hosp. / Biochemistry of some toxic agents. I. Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning by Peters (1955)
  109. 10.1021/tx000264z / Chem. Res. Toxicol. / Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase by Petrick (2001)
  110. 10.1016/S0891-5849(00)00209-4 / Free Radical Biol. Med. / Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia by Pi (2000)
  111. 10.1289/ehp.02110331 / Environ. Health Perspect. / Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water by Pi (2002)
  112. 10.1016/S0021-9258(17)35716-2 / J. Biol. Chem. / Characterization of affinity-purified insulin receptor/kinase. Effects of dithiothreitol on receptor/kinase function by Pike (1986)
  113. 10.1136/oem.52.11.773 / Occup. Environ. Med. / Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter by Rahman (1995)
  114. 10.5271/sjweh.123 / Scand. J. Work, Environ. Health / Diabetes mellitus among Swedish art glassworkers—An effect of arsenic exposure? by Rahman (1996)
  115. 10.1093/oxfordjournals.aje.a009624 / Am. J. Epidemiol. / Diabetes mellitus associated with arsenic exposure in Bangladesh by Rahman (1998)
  116. 10.1136/oem.56.4.277 / Occup. Environ. Med. / Relations between exposure to arsenic, skin lesions, and glucosuria by Rahman (1999)
  117. 10.1126/science.2442814 / Science / After insulin binds by Rosen (1987)
  118. 10.1016/S0014-5793(02)03186-1 / FEBS Lett. / Biochemistry of arsenic detoxification by Rosen (2002)
  119. 10.1074/jbc.M301977200 / J. Biol. Chem. / Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects by Rotter (2003)
  120. 10.1080/07315724.2003.10719310 / J. Am. Coll. Nutr. / Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus by Roussel (2003)
  121. {'key': '10.1016/j.taap.2004.02.009_BIB121', 'first-page': 'E935', 'article-title': 'Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes', 'volume': '272', 'author': 'Rudich', 'year': '1997', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes by Rudich (1997)
  122. 10.1021/tx000154s / Chem. Res. Toxicol. / Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue by Sampayo-Reyes (2000)
  123. 10.1016/S0008-6363(03)00472-3 / Cardiovasc. Res. / Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1 by Santalucia (2003)
  124. 10.1016/j.dnarep.2003.09.001 / DNA Repair / Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg by Schwerdtle (2003)
  125. 10.1093/carcin/bgg018 / Carcinogenesis / Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA by Schwerdtle (2003)
  126. 10.1161/01.HYP.0000066846.46422.2C / Hypertension / Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress by Shimosawa (2003)
  127. 10.1254/jphs.91.187 / J. Pharmacol. Sci. / Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state by Shinozaki (2003)
  128. {'key': '10.1016/j.taap.2004.02.009_BIB128', 'first-page': '3445', 'article-title': 'Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation', 'volume': '60', 'author': 'Simeonova', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation by Simeonova (2000)
  129. 10.1042/0264-6021:3590639 / Biochem. J. / GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase by Somwar (2001)
  130. 10.2337/diacare.27.1.59 / Diabetes Care / Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women by Song (2004)
  131. {'key': '10.1016/j.taap.2004.02.009_BIB131', 'first-page': 'E159', 'article-title': 'Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport', 'volume': '255', 'author': 'Sowell', 'year': '1988', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport by Sowell (1988)
  132. 10.1074/jbc.272.48.30075 / J. Biol. Chem. / Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport by Standaert (1997)
  133. 10.1007/PL00000669 / Cell. Mol. Life Sci. / Selenium: an insulin-mimetic by Stapleton (2000)
  134. 10.1007/s00775-002-0366-y / J. Biol. Inorg. Chem. / The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats by Sun (2002)
  135. 10.1161/01.HYP.0000100443.09293.4F / Hypertension / Reactive oxygen species in the vasculature: molecular and cellular mechanisms by Taniyama (2003)
  136. 10.2337/diabetes.46.11.1733 / Diabetes / Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells by Tiedge (1997)
  137. 10.1016/S0161-813X(03)00029-9 / Neurotoxicology / The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence by Tsai (2003)
  138. 10.1177/000331970205300505 / Angiology / An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan by Tseng (2002)
  139. 10.1016/j.toxlet.2003.08.007 / Toxicol. Lett. / Abnormal current perception thresholds measured by neurometer among residents in blackfoot disease hyperendemic villages in Taiwan by Tseng (2003)
  140. 10.1289/ehp.00108847 / Environ. Health Perspect. / Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan by Tseng (2000)
  141. 10.1016/S0378-4274(02)00085-1 / Toxicol. Lett. / Epidemiologic evidence of diabetogenic effect of arsenic by Tseng (2002)
  142. 10.1016/S0378-4274(02)00377-6 / Toxicol. Lett. / Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan by Tseng (2003)
  143. 10.1126/science.1987644 / Science / CCAAT-enhancer binding protein: a component of a differentiation switch by Umek (1991)
  144. 10.1210/jc.2003-030202 / J. Clin. Endocrinol. Metab. / Oxidative stress is associated with adiposity and insulin resistance in men by Urakawa (2003)
  145. 10.1002/(SICI)1097-4652(199611)169:2<256::AID-JCP5>3.0.CO;2-N / J. Cell. Physiol. / Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species by Wang (1996)
  146. 10.1093/toxsci/65.2.211 / Toxicol. Sci. / Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis by Wauson (2002)
  147. 10.1016/0005-2736(89)90253-8 / Biochim. Biophys. Acta / Effects of three proposed inhibitors of adipocyte glucose transport on the reconstituted transporter by Wheeler (1989)
  148. 10.1016/S0021-9258(17)42297-6 / J. Biol. Chem. / The insulin signaling system by White (1994)
  149. 10.1046/j.1365-201x.2001.00855.x / Acta Physiol. Scand. / Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction by Widegren (2001)
  150. 10.1093/toxsci/61.2.283 / Toxicol. Sci. / Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices by Wijeweera (2001)
  151. 10.1289/ehp.6396 / Environ. Health Perspect. / Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects by Wu (2003)
  152. 10.1016/0006-291X(89)91031-0 / Biochem. Biophys. Res. Commun. / Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice by Yamanaka (1989)
  153. 10.1016/0006-291X(90)91674-H / Biochem. Biophys. Res. Commun. / Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical by Yamanaka (1990)
  154. 10.1016/0041-008X(91)90111-Q / Toxicol. Appl. Pharmacol. / Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice by Yamanaka (1991)
  155. 10.1016/S1383-5718(97)00130-7 / Mutat. Res. / Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics by Yamanaka (1997)
  156. 10.1248/bpb.24.510 / Biol. Pharm. Bull. / Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter by Yamanaka (2001)
  157. 10.1080/713715229 / Endothelium / Modulation of the arsenic effects on cytotoxicity, viability, and cell cycle in porcine endothelial cells by selenium by Yeh (2003)
  158. 10.1046/j.1523-1747.2002.00475.x / J. Invest. Dermatol. / Arsenic induces tumor necrosis factor alpha release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis by Yu (2002)
Dates
Type When
Created 21 years, 4 months ago (April 22, 2004, 7:44 a.m.)
Deposited 2 years, 4 months ago (April 28, 2023, 8:27 a.m.)
Indexed 1 week, 4 days ago (Aug. 26, 2025, 2:30 a.m.)
Issued 21 years, 3 months ago (June 1, 2004)
Published 21 years, 3 months ago (June 1, 2004)
Published Print 21 years, 3 months ago (June 1, 2004)
Funders 0

None

@article{Tseng_2004, title={The potential biological mechanisms of arsenic-induced diabetes mellitus}, volume={197}, ISSN={0041-008X}, url={http://dx.doi.org/10.1016/j.taap.2004.02.009}, DOI={10.1016/j.taap.2004.02.009}, number={2}, journal={Toxicology and Applied Pharmacology}, publisher={Elsevier BV}, author={Tseng, Chin-Hsiao}, year={2004}, month=jun, pages={67–83} }